HOX GENE

Clinical trials for HOX GENE explained in plain language.

Never miss a new study

Get alerted when new HOX GENE trials appear

Sign up with your email to follow new studies for HOX GENE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New pill targets genetic driver in Tough-to-Treat leukemias

Disease control Recruiting now

This study is testing an oral drug called revumenib to see if it can help control leukemia that has returned or not responded to other treatments and is driven by specific genetic changes involving HOX genes. It will enroll about 40 patients aged 12 and older. The main goals are …

Matched conditions: HOX GENE

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

HOX GENE

Get alerted when new HOX GENE trials appear

New pill targets genetic driver in Tough-to-Treat leukemias